Publication Date: 

Please note: The following notice only applies to inpatient claims by facility providers. 

CMS implemented 12 new procedure codes in response to COVID-19 to describe the introduction or infusion of therapeutics, including remdesivir and convalescent plasma, into the International Classification of Diseases, Tenth Revision, Procedure Coding System (ICD-10-PCS). 

These codes can only be used on inpatient facility claims with a procedure date of service on or after Aug. 1, 2020. Claims containing these codes with a date of service prior to Aug. 1, 2020, will be rejected and mailed back to the provider. 

Click here for additional coding and claim submission guidance for Blue Cross NC’s COVID-19 measures. If you have specific questions about your COVID-19-related claims, please complete this form